HU Jing, XU Jialu, HAN Manman, DONG Qi, YANG Jun, MIAO Hong, XU Xiaofang. Pharmacoeconomics analysis of the traditional Chinese medicine injections for invigorating blood circulation and eliminating stasis in cervical spondylosis patients with non-surgical treatment[J]. Journal of Clinical Medicine in Practice, 2020, 24(7): 108-111. DOI: 10.7619/jcmp.202007031
Citation: HU Jing, XU Jialu, HAN Manman, DONG Qi, YANG Jun, MIAO Hong, XU Xiaofang. Pharmacoeconomics analysis of the traditional Chinese medicine injections for invigorating blood circulation and eliminating stasis in cervical spondylosis patients with non-surgical treatment[J]. Journal of Clinical Medicine in Practice, 2020, 24(7): 108-111. DOI: 10.7619/jcmp.202007031

Pharmacoeconomics analysis of the traditional Chinese medicine injections for invigorating blood circulation and eliminating stasis in cervical spondylosis patients with non-surgical treatment

More Information
  • Received Date: December 19, 2019
  • Objective To evaluate the economic efficiency of the traditional Chinese medicine injection for invigorating blood circulation and eliminating stasis in cervical spondylosis patients with non-surgical treatment, providing economical, effective and safe treatment options for cervical spine disease. Methods A total of 242 inpatients diagnosed as cervical spondylosis in four comprehensive hospitals in the region between 2015 and 2017 were selected as study subjects by retrospective study method, and were divided into observation group(n=177)and control group(n=65)according to therapeutic schedule. The observation group was given traditional Chinese medicine injection for invigorating blood circulation and eliminating stasis, while the control group was not given the same therapy. Therapeutic efficacy, the occurrence of adverse reactions and cost during treatment of two groups were recorded. Cost-minimization method was given to the two groups for analysis. Results The cure - rates of observation group and control group were 2.8%, 4.6%, respectively; improvement rates were 97.2%, 93.8%, respectively. There were no statistical significant differences in cure rate and improvement rate(P>0.05). The total medical cost per person of two groups were 13 154.4, 12 276.2 Yuan, respectively, and the observation group was higher than control group, and the results of sensitivity analysis were consistent with the results of cost-minimization analysis. Conclusion For non-surgical treatment patients with cervical spondylosis, there is no significant difference in the efficacy of treatment with or without TCM injection for invigorating blood circulation and eliminating stasis, but TCM injection has higher cost, but no economic advantage. Therefore, the phenomenon of the extensive use of TCM injection for invigorating blood circulation and eliminating stasis in the treatment of cervical spondylosis deserves deep consideration. It is hoped that relevant departments will adopt corresponding normative measures in this regard.
  • 张茂狮. 颈椎病非手术治疗复发率统计分析及对策[J]. 福建中医药, 1998, 29(3): 37-38.
    郭翔, 徐李鹏, 徐锋, 等. 复方丹参注射液联合针灸对颈椎病患者血流动力学的影响研究[J]. 上海医药, 2015, 36(17): 35-38.
    张晓鹿, 马泽彬, 许大庆. 某院骨科活血化瘀类中药注射剂临床应用情况及干预效果[J]. 宁夏医科大学学报, 2016, 38(6): 692-694.
    陈令允. 活血化瘀类中药注射液的临床应用与安全性分析[J]. 中医药信息, 2013, 30(1): 107-109.
    王宇晨. 程氏推拿手法治疗椎动脉型颈椎病的临床研究[D]. 广州: 广州中医药大学, 2017.
    孙宇, 陈贵存. 第二届颈椎病专题座谈会议纪要[J]. 解放军医学杂志, 1994, 19(2): 156-158.
    朱立国, 于杰. 非手术疗法治疗神经根型颈椎病的研究进展[J]. 中国中医骨伤科杂志, 2011, 19(4): 66-69.
    孙利华. 药物经济学[M]. 北京: 人民卫生出版社, 2014: 37-42.
    国家中医药管理局. 中华人民共和国中医药行业标准: 中医病证诊断疗效标准[M]. 南京: 南京大学出版社, 1994: 136-136.
    孙利华, 宗欣. 对我国药物经济学评价中贴现率选择问题的思考[J]. 中国新药杂志, 2010, 19(9): 737-739.
    孙利华. 药物经济学[M]. 北京: 人民卫生出版社, 2014: 65-71.
    吴久鸿. 药物经济学[M]. 北京: 高等教育出版社, 2017: 15-29.
    周国威. 活血化瘀类中药注射剂药品不良反应临床研究[J]. 中国处方药, 2018, 16(10): 58-59.
    刘爽, 乔艳, 刘高峰. 中药注射剂不良反应与不合理用药问题分析[J]. 中南药学, 2016, 14(11): 1177-1182.
    赵景菊, 赵锦, 刘保良, 等. 老年患者应用活血化瘀类中药注射剂不良反应及应对策略[J]. 临床合理用药杂志, 2016, 9(11): 80-82.
    许晓东, 钱泳. 我院活血化瘀类中药注射剂临床使用情况的调查分析[J]. 中国现代药物应用, 2019, 13(21): 217-219.
    赵美, 王钰. 某中医医院骨伤科住院部中药注射剂使用分析[J]. 中国卫生产业, 2017, 14(4): 110-111.
    沈国琴, 黄贵平. 我院骨科活血化瘀中药注射剂使用情况分析[J]. 中国药业, 2014, 23(16): 66-68.

Catalog

    Article views (363) PDF downloads (8) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return